Brief: Titan Pharmaceuticals Announces Addition Of Probuphine To Federal Supply Schedule
13/01/2020 13:32
Jan 13 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES ADDITION OF PROBUPHINE® TO
FEDERAL SUPPLY SCHEDULE
* TITAN PHARMACEUTICALS - HAS SIGNED AGREEMENT FOR
PROBUPHINE
IMPLANT TO BE INCLUDED ON FEDERAL SUPPLY SCHEDULE
* TITAN PHARMACEUTICALS - FINAL FSS CONTRACT IS EFFECTIVE
JANUARY
15, 2020 AND HAS A FIVE-YEAR TERM
Source text for Eikon: ID:nPnbx2hFsa
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.